US Patent 8008447 Crystallization of antibody or fragment thereof
Patent 8008447 was granted and assigned to Genentech on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+358 characters)
Article
Patent abstract
The present disclosure concerns methods of crystallization and/or concentration of antibody or antibody fragments. The methods comprise contacting an antibody or antibody fragment with a solution comprising a salt of a divalent cation. Crystals and/or protein gels of antibody or antibody fragments are useful in compositions and formulations.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Annette Marie Clasen Hagewiesche0
Julie Fukami0
Mary E. M. Cromwell0
Rachel Bulotsky Dinges0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08008447 Crystallization of antibody or fragment thereof US Patent 8008447 Crystallization of antibody or fragment thereof
Infobox
Patent Number
080084470
Patent Number
80084470
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080084470
Date of Patent
August 30, 2011
0Patent Application Number
115723690
Date Filed
July 22, 2005
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08008447 Crystallization of antibody or fragment thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08008447
Date of patent
August 30, 2011
Patent application number
11572369
Date Filed
July 22, 2005
Patent primary examiner
Find more entities like US Patent 8008447 Crystallization of antibody or fragment thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
